相关实验视频
Updated: Jan 11, 2026

09:12
Nanoparticle-mediated siRNA Gene-silencing in Adult Zebrafish Heart
Published on: July 29, 2018
8.5K
齐勒贝西兰作为一种基于siRNA的高血压的创新治疗方法:心血管医学新兴前景
Petruta A Morosan1, Amelian M Bobu1, Alexandru Carauleanu1
1Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania.
International journal of molecular sciences
|November 13, 2025
概括
齐勒贝西兰是一种新的小干扰RNA (siRNA) 疗法,单剂量可显著降低缩血压,持续长达24周. 这种创新的治疗方法对难以控制的高血压的管理有希望.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 在RNA治疗方面,RNA疗法.
背景情况:
- 在全球范围内,高血压仍然是心血管疾病的主要原因.
- 当前的抗高血压治疗常常面临着在耐药病例中坚持和有效性的挑战.
- 氨酸- ангиотензин- алдостерон系统在血压调节中起着至关重要的作用.
研究的目的:
- 评估基于siRNA的抗高血压剂zilebesiran的疗效和安全性.
- 为了评估单剂量zilebesiran后降低血压的持久性.
- 探索针对高血压管理的血管激素向的潜力.
主要方法:
- 临床试验KARDIA-1和KARDIA-2评估了zilebesiran对缩血压的影响.
- 齐勒贝西兰在各种剂量下进行皮下注射,与安慰剂和标准治疗进行了比较.
- 研究的终点包括在特定时间点降低血压和安全性评估.
主要成果:
- 在KARDIA-1中,一次性皮下注射 (300毫克和每6个月600毫克) 的zilebesiran在3个月后导致显著的缩血压降低 (>15 mmHg).
- 在KARDIA-2中添加齐勒贝西兰,在3个月后提供了额外的血压降低 (高达12.1 mmHg).
- 该疗法表现出良好的安全性,副作用最小,效果持续长达24周.
结论:
- 齐勒贝西兰提供了一种新的,长效的抗高血压机制,通过抑制肝脏的血管新生素产生.
- siRNA疗法对抗性或不受控制的高血压患者有潜力,改善了坚持和心血管结果.
- 齐勒贝西兰可以提供除降低血压之外的器官保护,这代表了高血压管理的重大进步.
相关概念视频
siRNA - Small Interfering RNAs
18.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
902
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
902
Hypertension IV: Drug Therapy and Lifestyle Modifications
600
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
600
Antihypertensive Drugs: Vasodilators
2.0K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.0K
Antihypertensive Drugs: Thiazide-Class Diuretics
1.6K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
1.6K
Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
